Patents by Inventor Patrick Robert ROMANO

Patrick Robert ROMANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lectin Assay For Assessing Glycoforms As An Early Marker In Disease
    Publication number: 20210041458
    Abstract: The present invention provides methods, compositions, apparatus, and kits for assessing glycoforms of proteins as a biomarker for disease. A purified recombinant form of lectin is used as a detector molecule to specifically label target sugars expressed in disease states. The high affinity of recombinant lectin allows for automation of assays that would be used in the diagnosis of diseases such as, but not limited to, cancer or liver disease.
    Type: Application
    Filed: October 26, 2020
    Publication date: February 11, 2021
    Inventors: Patrick Robert Romano, Anand Mehta, Timothy M. Block
  • Lectin Assay For Assessing Glycoforms As An Early Marker In Disease
    Publication number: 20160327571
    Abstract: The present invention provides methods, compositions, apparatus, and kits for assessing glycoforms of proteins as a biomarker for disease. A purified recombinant form of lectin is used as a detector molecule to specifically label target sugars expressed in disease states. The high affinity of recombinant lectin allows for automation of assays that would be used in the diagnosis of diseases such as, but not limited to, cancer or liver disease.
    Type: Application
    Filed: July 20, 2016
    Publication date: November 10, 2016
    Inventors: Patrick Robert Romano, Anand Mehta, Timothy M. Block
  • Lectin Assay for Assessing Glycoforms as an Early Marker in Disease
    Publication number: 20150198610
    Abstract: The present invention provides methods, compositions, apparatus, and kits for assessing glycoforms of proteins as a biomarker for disease. A purified recombinant form of lectin is used as a detector molecule to specifically label target sugars expressed in disease states. The high affinity of recombinant lectin allows for automation of assays that would be used in the diagnosis of diseases such as, but not limited to, cancer or liver disease.
    Type: Application
    Filed: February 3, 2012
    Publication date: July 16, 2015
    Applicants: Baruch S. Blumberg Institute, Drexel University
    Inventors: Patrick Robert ROMANO, Anand MEHTA, Timothy M. Block
  • Lectin Assay for Assessing Glycoforms as an Early Marker in Disease
    Publication number: 20130203092
    Abstract: The present invention provides methods, compositions, apparatus, and kits for assessing glycoforms of proteins as a biomarker for disease. A purified recombinant form of lectin is used as a detector molecule to specifically label target sugars expressed in disease states. The high affinity of recombinant lectin allows for automation of assays that would be used in the diagnosis of diseases such as, but not limited to, cancer or liver disease.
    Type: Application
    Filed: February 3, 2012
    Publication date: August 8, 2013
    Applicant: INSTITUTE FOR HEPATITIS AND VIRUS RESEARCH
    Inventors: Patrick Robert ROMANO, Anand MEHTA, Timothy M. Block